Showing results (181-190 of 198) with videos related to
Sort By:
Pageof 20
The Journal of Dermatological Treatment|July 13, 2026
Safety and effectiveness of omalizumab for chronic spontaneous urticaria inadequately controlled with H1 antihistamines in Chinese adolescents: a real-world, prospective, multicenter studyYu Wang, Chengzhi Lv, Bin Yang, et al.Cell & Bioscience|January 6, 2026
IL-27 signaling mediates skin inflammation in experimental psoriasis and atopic dermatitisZeyu Chen, Lian Cui, Zhiyi Lan, et al.Stem Cell Reviews and Reports|May 18, 2023
Comparative Analysis of the Therapeutic Effects of Fresh and Cryopreserved Human Umbilical Cord Derived Mesenchymal Stem Cells in the Treatment of PsoriasisZhifeng Wang, Yifan Hu, Xiaoyu Wang, et al.Scientific Reports|October 29, 2024
A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasisHuiwei Wang, Jialiang Shi, Suchun Hou, et al.The British Journal of Dermatology|March 16, 2026
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate to severe chronic spontaneous urticaria patients with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot studyXu Yao, Yi Liu, Yang Luo, et al.Cellular & Molecular Immunology|June 23, 2025
Dermal adipogenesis protects against neutrophilic skin inflammation during psoriasis pathogenesisTian Xia, Wenlu Zhang, Rundong Wu, et al.Journal of the American Academy of Dermatology|April 5, 2026
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque PsoriasisYunlu Gao, Lanying Qin, Yumei Li, et al.The New England Journal of Medicine|November 5, 2025
Oral Icotrokinra for Plaque Psoriasis in Adults and AdolescentsRobert Bissonnette, Jennifer Soung, Adelaide A Hebert, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
Reprogramming of Fatty Acid Metabolism via PPARα-Orchestrated FADS2 in Keratinocytes Modulates Skin Inflammation in PsoriasisJiangluyi Cai, Xue Zhou, Yu Zhuang, et al.Nature Immunology|October 21, 2022
IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammationXinhui Ni, Yi Xu, Wang Wang, et al.Pageof 20